Tuesday, May 08, 2012
-
Dynavax Embarks on Transition to Commercialization (DVAX, News, FDA / Tue, 04:03pm)
Thursday, April 26, 2012
-
Dynavax Reports HEPLISAV BLA Submission (DVAX, News, FDA / Thu, 04:00pm)
Tuesday, March 27, 2012
Monday, February 13, 2012
-
Phase 3 Data on HEPLISAV in Adults Aged 18-55 Published in VACCINE (DVAX, News, FDA / Mon, 10:01am)
Thursday, February 02, 2012
-
Dynavax Reports on Heplisav(TM) Pre-BLA Meeting With FDA (DVAX, News, FDA / Thu, 10:01am)
Wednesday, December 21, 2011
Tuesday, December 20, 2011
-
Dynavax Initiates Proof of Mechanism Trial in Lupus Patients (DVAX, GSK, News, FDA / Tue, 10:06am)
Thursday, October 27, 2011
-
Dynavax Confirms HEPLISAV Submission Strategies With U.S. FDA and EMA (DVAX, MAA, News, FDA / Thu, 04:10pm)
Friday, October 21, 2011
Monday, October 10, 2011
Thursday, October 06, 2011
Wednesday, October 05, 2011
-
Dynavax and AstraZeneca to Advance TLR-9 Agonist Into Clinic (DVAX, News, FDA / Wed, 09:00am)
Monday, October 03, 2011
Sunday, September 18, 2011
-
Dynavax Reports Complete Results From the HEPLISAV Phase 3 Trial (DVAX, News, FDA, Events / Sun, 04:14pm)
Thursday, July 28, 2011
-
FDA Agrees with Dynavax on Consistency of HEPLISAV Lots (DVAX, News, FDA / Thu, 08:14am)
Wednesday, July 20, 2011
-
Dynavax Phase 3 Demonstrates Superiority and Safety of HEPLISAV vs. Engerix-B (DVAX, News, FDA / Wed, 08:03am)
Wednesday, May 25, 2011
-
Dynavax Completes Phase 3 Study of HEPLISAV (DVAX, News, FDA / Wed, 04:31pm)
Wednesday, April 20, 2011
-
Dynavax Initiates First Human Trial in Lupus Program (DVAX, GSK, News, FDA / Wed, 12:31pm)
